Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that the first patient has been ...
People with strabismus, myopia, amblyopia, and other common eye conditions are 40% more likely to develop attention-deficit/hyperactivity disorder (ADHD) than those ...
Autism Spectrum Disorder (ASD) is a lifelong neurodevelopmental disorder characterized by social communication and interaction difficulties as well as repetitive behaviors. In recent years, there has ...
The number of people in Europe diagnosed with attention deficit hyperactivity disorder (ADHD) has continued to rise steadily, not only among children, but increasingly among adults and women. Despite ...
Children born very preterm (VPT) are at high risk for attention problems. This study’s purpose was to describe the Conners Kiddie Continuous Performance Test (K-CPT) assessment in children born VPT, ...
Understood reports ADHD, originally known as ADD, is now officially termed attention-deficit hyperactivity disorder, with new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results